Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis

Author:

Chokesuwattanaskul Ronpichai1ORCID,Thongprayoon Charat2ORCID,Tanawuttiwat Tanyanan3,Kaewput Wisit4,Pachariyanon Pavida5,Cheungpasitporn Wisit6

Affiliation:

1. Division of Cardiology, Department of Medicine, Faculty of Medicine; Chulalongkorn University and King Chulalongkorn Memorial Hospital; Bangkok Thailand

2. Department of Internal Medicine; Bassett Medical Center; Cooperstown NY USA

3. Division of Cardiology, Department of Medicine; University of Mississippi Medical Center; Jackson MS USA

4. Department of Military and Community Medicine; Phramongkutklao College of Medicine; Bangkok Thailand

5. Department of Internal Medicine; Texas Tech University Health Sciences Center; Lubbock TX USA

6. Division of Nephrology, Department of Medicine; University of Mississippi Medical Center; Jackson MS USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference45 articles.

1. NIH Kidney Disease Statistics for the United States 2016 https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease

2. Chronic kidney disease increases risk for venous thromboembolism;Wattanakit;J Am Soc Nephrol,2008

3. Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan;Shen;Medicine,2016

4. Renal impairment in patients with thromboembolic event: Prevalence and clinical implications. A systematic review of the literature;Wilke;Deutsche medizinische Wochenschrift,2015

5. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials;Ruff;Lancet,2014

Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3